Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Vilas Transcore Regulatory Approval

Vilas Transcore Limited received Consolidated Consent and Authorization (CCA-Fresh) from the Gujarat Pollution Control Board for its new industrial plant in Vadodara. This regulatory milestone enables the company to commence manufacturing products at the facility. The plant is located at Survey Nos. 419 & 420, Village Ganpatpura, Taluka Karjan.

Source

NSE filing, NSE: VILAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vilas Transcore Ltd: key numbers

Share price
₹344.00
Market cap
₹842.1 Cr
Revenue (annual)
₹460.7 Cr
Net profit (annual)
₹39.56 Cr
P/E (TTM)
21.3×Sector 52.8×
Promoter holding
73.14%
FII holding
3.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vilas Transcore Ltd

All →
16:32 IST NSE
Product Launch

Vilas Transcore Product Launch

Vilas Transcore Limited has launched a new line of Paper Covered Copper and Aluminium Conductors. This product expansion enhances its offerings in the transformer components segment.

Other regulatory approval announcements

All →
08:07 IST BSE
Regulatory ApprovalHikal Ltd HIKAL

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

08:05 IST BSE
Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

20:00 IST NSE
Regulatory ApprovalRNFI Services Ltd RNFI

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

18:40 IST NSE
Regulatory ApprovalShalby Ltd SHALBY

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

23:24 IST BSE
Regulatory ApprovalElantas Beck India Ltd ELANTAS

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.